Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

2.81
+0.04001.44%
Volume:70.03K
Turnover:197.67K
Market Cap:81.45M
PE:-1.15
High:2.86
Open:2.80
Low:2.78
Close:2.77
Loading ...

BRIEF-Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals

Reuters
·
Yesterday

Aerovate Therapeutics Inc - Stockholders Approve Merger With Jade Biosciences

THOMSON REUTERS
·
Yesterday

Aerovate Therapeutics Inc - Board Approves 1-for-35 Reverse Stock Split

THOMSON REUTERS
·
Yesterday

Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals

PR Newswire
·
Yesterday

Aerovate Announces Special Dividend Amid Jade Merger

TIPRANKS
·
10 Apr

BRIEF-Aerovate Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Jade Biosciences

Reuters
·
10 Apr

Aerovate Therapeutics declares special cash dividend, estimated $2.40 per share

TIPRANKS
·
10 Apr

Aerovate Therapeutics Declares Special Cash Dividend in Connection With the Proposed Merger With Jade Biosciences

THOMSON REUTERS
·
10 Apr

Aerovate Therapeutics Inc: Cash Dividend Will Be an Aggregate of $69.6 Mln, or an Estimated $2.40 per Share

THOMSON REUTERS
·
10 Apr

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences

PR Newswire
·
10 Apr

BRIEF-Aerovate Therapeutics Announces Range Of Expected Cash Dividend

Reuters
·
07 Apr

Aerovate Therapeutics Announces Merger with Jade Biosciences

TIPRANKS
·
07 Apr

Aerovate Therapeutics sees $67.6M-$69.6M dividend in connection with Jade

TIPRANKS
·
07 Apr

Aerovate Therapeutics Inc - Cash Dividend Expected to Be in Range of $67.6 - 69.6 Mln

THOMSON REUTERS
·
07 Apr

Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences

PR Newswire
·
07 Apr

Aerovate Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Aerovate Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
22 Mar

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting

Business Wire
·
19 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 Nov 2024